Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal models

Abstract

Adenoviral gene therapy could potentially be used for treatment of patients with a Barrett's esophagus. In order to study the feasibility of this approach it is important to study adenoviral intestinal transduction both in vitro and in vivo. In the present study, we used differentiating Caco-2 cells, closed intestinal loops and a Barrett's esophagus rat model to test transduction of adenoviruses expressing green fluorescent protein. We observed a decreased adenoviral transduction from 18.6 to 2.3% in undifferentiated and differentiated Caco-2 cells, respectively. This could be improved by the use of the mucolytic agent N-acetylcysteine (NAC) and the polycation diethylaminoethyl-dextran (DEAE-dextran), which improved transduction in differentiated cells five- and ten-fold, respectively. Also an RGD-retargeted adenovirus showed an improved transduction in differentiated cells. In closed intestinal loops adenoviral transduction was limited and the use of NAC and DEAE-dextran or RGD targeting had little effect. The Barrett's esophagus rat model consisted of an esophagojejunostomy, which results in a Barrett's esophagus and esophageal tumors within 6 months. Adenoviral transduction in this model was limited and mainly localized in the basal layer of normal esophagus and stromal tissue of a Barrett's segment. We conclude that although the adenovirus shows promising results in vitro, the current adenoviral vectors are probably not suitable for patients with Barrett's esophagus.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Cameron AJ, Ott BJ, Payne WS . The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985;313:857–859.

    Article  CAS  PubMed  Google Scholar 

  2. Devesa SS, Blot WJ, Fraumeni Jr JF . Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053.

    Article  CAS  PubMed  Google Scholar 

  3. Sharma P . An update on strategies for eradication of Barrett's mucosa. Am J Med. 2001;111 (Suppl 8A): 147S–152S.

    Article  PubMed  Google Scholar 

  4. Schmid RM, Weidenbach H, Draenert GF, et al. Liposome mediated gene transfer into the rat oesophagus. Gut. 1997; 41:549–556.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hidalgo IJ, Raub TJ, Borchardt RT . Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989;96:736–749.

    Article  CAS  PubMed  Google Scholar 

  6. Meunier V, Bourrie M, Berger Y, et al. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol. 1995;11: 187–194.

    Article  CAS  PubMed  Google Scholar 

  7. Hulscher JB, Buskens CJ, Huyzer G, et al. An animal model for Barrett's oesophagus but not for Barrett's cancer. Thesis, University of Amsterdam. 2004.

  8. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320–1323.

    Article  CAS  PubMed  Google Scholar 

  9. Krasnykh V, Dmitriev I, Mikheeva G, et al. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol. 1998;72:1844–1852.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998;72:9706–9713.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Graham FL, Prevec L . Methods for construction of adenovirus vectors. Mol Biotechnol. 1995;3:207–220.

    Article  CAS  PubMed  Google Scholar 

  12. Marsman WA, Buskens CJ, Wesseling JG, et al. Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo. Cancer Gene Ther. 2004;11:289–296.

    Article  CAS  PubMed  Google Scholar 

  13. Westbrook CA, Chmura SJ, Arenas RB, et al. Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Mol Genet. 1994;3:2005–2010.

    Article  CAS  PubMed  Google Scholar 

  14. Schmid RM, Weidenbach H, Draenert GF, et al. Liposome mediated in vivo gene transfer into different tissues of the gastrointestinal tract. Z Gastroenterol. 1994;32:665–670.

    CAS  PubMed  Google Scholar 

  15. Cheng DY, Kolls JK, Lei D, et al. In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-deleted adenoviral vector. Hum Gene Ther. 1997;8:755–764.

    Article  CAS  PubMed  Google Scholar 

  16. Foreman PK, Wainwright MJ, Alicke B, et al. Adenovirus-mediated transduction of intestinal cells in vivo. Hum Gene Ther. 1998;9:1313–1321.

    Article  CAS  PubMed  Google Scholar 

  17. Walter E . Adenovirus mediated gene transfer to intestinal epithelial cells as a potential approach for oral delivery of peptides and proteins. J Controlled Rel. 1997;46:75–87.

    Article  CAS  Google Scholar 

  18. Lojda Z . Indigogenic methods for glycosidases. II. An improved method for beta-D-galactosidase and its application to localization studies of the enzymes in the intestine and in other tissues. Histochemie. 1970;23:266–288.

    Article  CAS  PubMed  Google Scholar 

  19. Croyle MA, Stone M, Amidon GL, et al. In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Therapy. 1998;5:645–654.

    Article  CAS  PubMed  Google Scholar 

  20. Cheng X, Ming X, Croyle MA . PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm Res. 2003;20:1444–1451.

    Article  CAS  PubMed  Google Scholar 

  21. Croyle MA, Roessler BJ, Hsu CP, et al. Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm Res. 1998;15:1348–1355.

    Article  CAS  PubMed  Google Scholar 

  22. Liptay S, Weidenbach H, Adler G, et al. Colon epithelium can be transiently transfected with liposomes, calcium phosphate precipitation and DEAE dextran in vivo. Digestion. 1998;59:142–147.

    Article  CAS  PubMed  Google Scholar 

  23. Kaplan JM, Pennington SE, St George JA, et al. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther. 1998;9:1469–1479.

    Article  CAS  PubMed  Google Scholar 

  24. Fasbender A, Zabner J, Chillon M, et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem. 1997;272:6479–6489.

    Article  CAS  PubMed  Google Scholar 

  25. Ferrari S, Kitson C, Farley R, et al. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Therapy. 2001;8:1380–1386.

    Article  CAS  PubMed  Google Scholar 

  26. Kitson C, Angel B, Judd D, et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Therapy. 1999;6:534–546.

    Article  CAS  PubMed  Google Scholar 

  27. Sandberg JW, Lau C, Jacomino M, et al. Improving access to intestinal stem cells as a step toward intestinal gene transfer. Hum Gene Ther. 1994;5:323–329.

    Article  CAS  PubMed  Google Scholar 

  28. Cryan SA, O’Driscoll CM . Mechanistic studies on nonviral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop. Pharm Res. 2003;20:569–575.

    Article  CAS  PubMed  Google Scholar 

  29. Greber UF . Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor. Rev Med Virol. 1998;8:213–222.

    Article  CAS  PubMed  Google Scholar 

  30. Jornot L, Morris MA, Petersen H, et al. N-acetylcysteine augments adenovirus-mediated gene expression in human endothelial cells by enhancing transgene transcription and virus entry. J Gene Med. 2002;4:54–65.

    Article  CAS  PubMed  Google Scholar 

  31. Cohen CJ, Shieh JTC, Pickles RJ, et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. PNAS. 2001;98:15191–15196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Beaulieu JF . Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. Prog Histochem Cytochem. 1997; 31:1–78.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Willem A Marsman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marsman, W., Buskens, C., Wesseling, J. et al. Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal models. Cancer Gene Ther 12, 778–786 (2005). https://doi.org/10.1038/sj.cgt.7700841

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700841

Keywords

This article is cited by

Search

Quick links